379 results
Page 6 of 19
424B5
2p2q wkj9pm
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
m28baxe6gfmv132
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K/A
jdx4a8ck0by83q
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
6xinq6b6yayp 4elh1
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
EX-99.1
w78ty5ydp1 5m9mdss
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
5w9fa07kqzw
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
8-K/A
95z cnbrvgv8ds8u9h
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K
pmiuje575sf4q5nqnezt
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
424B5
4djvj42 z1qelz
9 May 13
Prospectus supplement for primary offering
12:00am
8-K
j50 g5o5a9l7zu
7 May 13
Discovery Labs Reports First Quarter 2013 Financial Results
12:00am
8-K
9rgd55mh
15 Apr 13
Other Events
12:00am
8-K
75uwmg
2 Apr 13
Entry into a Material Definitive Agreement
12:00am
8-K/A
73djsp8dk
15 Mar 13
Financial Statements and Exhibits
12:00am
8-K
p2mxdnpicrjfckrwe8
13 Mar 13
Discovery Labs Reports Fourth Quarter 2012 Financial Results
12:00am